Background/Aims: Evidence supports a role for the extracellular calcium-sensing receptor (CaR) 
I.
Introduction:
The extracellular calcium-sensing receptor (CaR) is a 7-transmembrane spanning G-protein-coupled receptor commonly associated with the regulation of systemic Ca 2+ -homeostasis. However, numerous studies have now investigated the role of the CaR on proliferation in cells as diverse as fibroblasts [1] , astrocytoma [2] and osteoblasts [3] . In the colon, activation of the calcium receptor up regulates adherens junction proteins, and a loss of CaR expression is associated with abnormal differentiation and progression of carcinomas [4] . Similarly, in parathyroid tissue, CaR expression has been linked to proliferation of both carcinomas and adenomas [5] , whilst in keratinocytes, loss of CaR expression was associated with down regulation of the adherens junction and apoptosis [6] .
Inactivation of CaR expression has been shown to suppress the assembly of the cell adhesion associated epithelial-cadherin (ECAD) and -catenin-PI3K complex [6] . Previous studies on pancreatic β-cells demonstrate a close association between adherens junction proteins and secretory granules [7] . Neutralising ECAD-mediated cell adhesion decreases glucose-evoked synchronicity in Ca 2+ -signals between adjacent cells within islets [8] . Together, these findings suggest an intriguing link between cell-cell adhesion, CaR expression and proliferation in pancreatic β-cells.
The low mitotic index of adult β-cells leads to considerable technical difficulties in measuring β-cell proliferation in cells from primary islets. Previous studies demonstrate that although MIN6 cells are transformed, their proliferative capacity is regulated by extracellular signals, validating these clonal β-cells as a representative experimental model of β-cell proliferation [9] [10] [11] [12] [13] . Elevated extracellular calcium concentration [Ca 2+ ] e can activate p38 and p42/44 MAP kinases [13, 14] and increase cell proliferation [15] . In the current study, we have examined whether specific activation of the CaR using the calcimimetic R568, enhances -cell proliferation at physiologically appropriate concentrations of extracellular calcium. The involvement of MAPK in transducing signals from the CaR will be determined using the MEK/ERK inhibitors PD098059 and SU1498 [16] . Down-regulation of CaR induces down-regulation of the adherens junction proteins and reduces proliferative capacity in skin, colon and pancreatic -cells. Of particular interest is the regulation of catenin localisation, since catenins are known regulators of gene transcription that drive proliferation in β-cells [17, 18] . The balance of interactions between -catenin at the adherens junction and the cytosolic destruction complex (part of the Wnt signalling pathway) ultimately regulates how the catenins govern proliferative/apoptotic responses versus differentiated functions such as adhesion/secretion [18] . In the current study, we have assessed the effect of reduced CaR expression on proliferative capacity when the cells are grown as either 2-dimensional monolayers or 3-dimensional pseudoislets, to ascertain whether cell configuration and the degree of cell-cell contact, alters CaR expression and ultimately the -cell turnover. The degree of cell-cell adhesion will be reduced further by immuno-neutralising ECAD to test the effect on CaR-expression and calcium-mediated proliferation.
II. Materials and Methods:
Materials: MIN6 cells were obtained from Dr. Y.Oka and J.-I. Miyazaki (Univ. of Tokyo, Tokyo, Japan). DMEM, glutamine, penicillin-streptomycin, gelatin (from bovine skin), PBS, foetal bovine serum and trypsin-EDTA were from Sigma-Aldrich (Poole, Dorset, U.K.). The MEK inhibitor PD98059 and the inhibitor of ERK kinase activity, SU1498, were from Calbiochem (Nottingham, UK). The calcimimetic R568 was from Amgen Inc (Thousand Oaks, CA, USA). BrdU and Alexa Fluor 594 conjugated anti-BrdU were from Invitrogen (Molecular Probes, Eugene, Oregon, USA)
Maintenance of MIN6 cells:
MIN6 cells were maintained at 37C (95% O 2 /5% CO 2 ) in DMEM supplemented with 15% foetal calf serum (FCS), 2mM glutamine and 100U/ml penicillin/0.1mg/ml streptomycin (all Sigma Chemical Co. Poole, Dorset). Cells were passaged when 80% confluent every 3-4 days using Trypsin-EDTA. MIN6 pseudoislets (PI) were cultured under the same conditions as monolayers (M), in tissue culture flasks pre-coated with gelatin (1% w/v) [8] . MIN6 pseudoislets, formed after 5 days in gelatin-coated (1%) 6-well plates were incubated overnight in the presence of rat IgG (Sigma, UK) or rat anti-E-cadherin (Sigma UK product code U3254 -antiuvomorulin, raised against a mouse immunogen; final concentration, 68µg/ml). Effects upon PI and M morphology were assessed by light microscopy.
CaR expression in MIN6 cells
The preparation of cytosolic proteins and their subsequent separation by gel electrophoresis and electro-blotting onto Immobilon P membrane (Millipore, Watford,UK) were as described previously [19] . Briefly proteins (5g) were separated by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (4.5% stacking gel, 7.5% or 10% resolving gel) at 200volts for 50 minutes in electrophoresis buffer containing 25mmol/L Tris, 192mmol/L glycine and 0.1% (wt/vol) SDS. Proteins were transferred onto Immobilin P membrane in transfer buffer (25mmol/LTris, 192mmol/L glycine, 20% (vol/vol) methanol) for 1 hour at 100 volts; 4 o C. Following protein transfer, membranes were blocked in PBS-T (PBS plus 0.1% Tween-20) containing 20% (wt/vol) non-fat milk powder (Marvel, Premier Brands, Stafford, UK) for 1 hour at 25 o C and then washed with PBS-T for 15 minutes. Filters were analyzed with specific polyclonal rabbit anti-CaR serum (1:1000) raised against a synthetic peptide corresponding to residues 18-29 of the mouse CaR (CSAYGPDQRAQKK; Genosphere Biotechnologies, Paris, France) in PBS-T. After three 10 minute washes in PBS-T, the membranes were incubated with the secondary antibody (horseradish peroxidase-conjugated) antirabbit (diluted 1:3000) in PBS-T (0.05%) for 60 minutes at 25 o C followed by three 10 minutes washes in PBS-T. Specific proteins were detected using ECL detection reagent chemiluminescence system (Amersham Biosciences) and were visualized after exposure of membranes to X-ray film for 5 minutes. Control experiments were included where primary antibody was omitted, and filters were exposed to secondary antibody and ECL detection. CaR immunoreactivity in MIN6 cells was assessed by fluorescence immunocytochemistry as described previously [20] , using a polyclonal rabbit anti-CaR serum (1:1000, as above), and ALEXA 488-conjugated chicken anti-rabbit IgG (Pierce, Rockford, IL, USA; 1:2000, 1h).
Cell Proliferation
DNA synthesis as a marker of cell proliferation was assessed by measuring the incorporation of 5-bromo-2'-deoxyuridine (BrdU) in individual cells using micro-fluorimetric localisation of BrdUimmunoreactivity as described previously [13] . Briefly, MIN6 cells were seeded onto 3-aminopropyltriethoxysilane (APES) treated cover glass at a density of 30,000 cells/well and left to adhere overnight under standard tissue culture conditions (95% CO2/5%O2 37 °C) in DMEM supplemented with 15% FCS. Cells were then washed in sterile PBS and serum starved overnight in fresh DMEM containing glucose (5mM) and low calcium (0.5mM). As required, the MEK inhibitor PD98059 or SU1498 was applied as a 1hr pre-treatment, before adding the incubation media containing; calcium (0-10mM), calcimimetic (+/-R568 (1μM)) and +/-PD98059 or SU1498 (1-100μM). All solutions contained BrdU (10μM) for the final 2hr incubation. Cells were fixed with 4% paraformaldehyde (PFA) and their DNA denatured using 1M HCl (30min at RT) before incubating in Alexa-594-conjugated anti-BrdU (Molecular Probes, Invitrogen) at 1:200 and storing overnight at 4°C. After repeated washing (PBS /triton (0.01%)) BrdU incorporation was determined using an Axiovert 200 inverted fluorescent microscope (Carl Zeiss, Welwyn Garden City, UK). Six different wells in three separate experiments were used for each treatment and the number of BrdU-positive cells (red) compared to non-BrdUimmunoreactive cells (green), determined for several (4-6) arbitrary regions/well.
Data Analysis
Non-parametric tests were used for statistical analysis. Differences between two treatment groups were assessed by Mann Whitney U-Test. Data involving more than two treatment groups were assessed by one-way ANOVA with Tukey's test for post hoc analysis. Differences between treatments were considered significant when P<0.05 unless otherwise stated. The data was normalised to 100% and error bars expressed as mean±SEM are included on all graphs. All statistical analyses were performed using the Prism GraphPad software version 4.0 (San Diego, CA, USA).
III.
Results:
Expression of the CaR in insulin-immunoreactive cells:
As expected, MIN6 cells contain a large numbers of insulin-immunoreactive secretory granules and express the extracellular calcium-sensing receptor (CaR; Fig 1A/B) . CaR-immunoreactivity is distributed throughout the cytosol and at the margin of cell-cell contact (Fig 1B) . Cytosolic and membrane localisation of CaR protein was confirmed by Western blot analysis of nuclear, cytoskeletal, cytosolic and cell membrane fractions (see Fig 1D) . Similar diffuse CaR staining was observed in insulin-immunoreactive cells isolated from primary mouse pancreata. Here, CaR-expression was found to be primarily cytosolic, but did not associate with insulin-containing granules (Fig 1C) .
Figure1. The CaR is expressed in insulin-immunoreactive cells:
Insulin-immunoreactivity (green) and nuclear staining (visualised with DAPI, blue) in MIN6 cells is shown in panel (A). In the enlarged area (white box), a large number of insulin-rich secretory granules can be identified. (B) CaR expression (visualised using green ALEXA 488) demonstrates punctate cytosolic staining in addition to clear expression at the interface between adjacent cells. (C) Western blot analysis (D) confirmed that CaR (130kDa) expression was maximally expressed in the cytosolic and membrane fractions of MIN6 cells. Similar cytosolic localisation for the CaR protein (red) is observed in isolated insulin-immunoreactive cells (green) from primary mouse pancreata. The extent of colocalisation between insulin-immunoreactivity and CaR-expression was determined using Image J software (freeware obtainable from the National Institutes of Health Web site). The degree of co-illuminated pixels (yellow oval) was negligible, suggesting that the CaR is not co-localised on the secretory granules.
Activation of the CaR stimulates proliferation in insulin-immunoreactive cells:
The extracellular calcium-sensing receptor (CaR) has been shown to partly mediate changes in insulin secretion in response to small changes in the concentration of co-released divalent cations that follow nutrientevoked stimulation of pancreatic β-cells. As early mentioned in introduction, the CaR has also been shown to increase cell proliferation in a number of cell models [1, 2, 3] . In the present study, elevating the concentration of extracellular calcium ([Ca 2+ ] e ) from a nominal level (no added calcium) to 0.5, 5 and 10mM [Ca 2+ ] e produced a concentration dependent increase in BrdU-incorporation into MIN6 β-cell DNA, with a more marked rise in BrdU immunoreactivity observed in the presence of the higher concentrations of [Ca 2+ ] e , indicative of enhanced proliferation (154±12%, P=NS; 225±31%, P<0.05; 240±22%, P<0.01 respectively, n=3, see Fig 3A) . Large changes in the concentration of [Ca 2+ ] e can have numerous non-specific effects over and above any receptormediated changes. To increase the specificity of our study we co-incubated the calcimimetic compound R-568 (1μM) in the presence of low [Ca 2+ ] e (0.5mM, Fig 3B) . Under these conditions, even 0.5mM [Ca 2+ ] e significantly elevated BrdU-incorporation, indicative of enhanced proliferation (218±37% with R568, compared to 154%±12% for Ca ] e (0.5mM) were significantly enhanced in the presence of the calcimimetic R568. Data represent mean ± SEM where * denotes P<0.05 and **P<0.01; n=3 for each.
The role of cell-cell contact on CaR expression/localisation:
MIN6 cells can form highly coupled 3-dimensional islet-like structures in culture (see Fig 2A, top  panel) . These 'pseudoislets' (PIs) have been shown to exhibit increased cell-to-cell contact and improved glucose-evoked insulin secretion in comparison to their monolayer (M) counterparts [38] . Cell-to-cell interactions result primarily from ligation between epithelial (E)-cadherin (ECAD), which acts as a tether between adjacent cells to facilitate cell-cell coupling [8] . In the present study, CaR expression increased 75% in cells cultured as, monolayers as compared to passage-matched PIs equivalents (Fig 2B, 177±8.5%, n=3; P<0.05) . Six-day culture of cells (passage 42-44) as pseudoislets in low (0.5mM) extracellular calcium reduced the proliferative capacity of the cells compared to their monolayer counterparts (Fig 2D,  P<0.001) . However, addition of the calcimimetic R568 (1μM) partially improved proliferation, although it still remained significantly lower than calcimimetic activated proliferation in monolayers.
Inhibition of MAP Kinase prevents proliferation in insulin-immunoreactive cells:
It has been previously reported that p42/44 MAPK are active in unstimulated MIN6 cells [13] . Exposure of MIN6 monolayers to the MEK inhibitor PD98059 (1-100μM; Fig 4A) significantly reduced basal (0.5mM) [Ca 2+ ]e-evoked proliferation as determined by BrdU-incorporation (86±10%, P=NS; 52±1%, P<0.01; 11±11%, P<0.001 respectively compared to nominal calcium, where n=3). In addition, the effect of the ERK inhibitor SU1498 on β-cell proliferation was also assessed. Figure 4B indicates that inhibition of ERK activity, by exposure of β-cells to SU1498 had similar effects to PD98059 on β-cell proliferation. Thus, SU1498 significantly reduced BrdU incorporation into MIN6 β-cell DNA in a dose related manner (1-100μM: 52±12%, P<0.01; 43±6%, P<0.01 and 3±3%, P<0.001 respectively compared to nominal calcium, where n=3).
Figure4. The effect inhibiting the MAP kinase pathway on BrdU incorporation into MIN6 β-cell DNA:
MIN6 β-cells were seeded onto APES-coated coverslips (50,000 cells/well) and the cells allowed to adhere for overnight. The cells were incubated for a further 24hr in the presence of low extracellular calcium (0.5mM). The inhibitors were present for the final 3hrs of the incubation and BrdU (10μM) was added for the final 2hrs. Fluorescence microscopy was used to detect BrdU incorporation using an ALEXA 594-tagged anti-BrdU antibody. (A) Inhibition of the p42/44 MAPK pathway using the MEK inhibitor PD098059 (1-100μM) significantly reduced proliferation in a concentration-dependent manner. (B) Similar inhibition was obtained using SU1498 (1-100μM) which inhibits ERK kinase activity. Data represent mean ± SEM where ** denotes P<0.01 and ***P<0.001; n=3 for each.
CaR-mediated proliferation is mediated by MAP kinase:
The calcimimetic compound R568 significantly elevated basal (0.5mM) [Ca 2+ ]e-evoked proliferation in MIN6 cells as determined by BrdU-incorporation (171±18%, P<0.01, n=3). This CaR-evoked increase in cell turn over was dramatically reduced by both PD98059 (100μM, 29±5.1%, P<0.001) and SU1498 (100μM, 7±2%, P<0.001), indicating that CaR-induced proliferation is mediated by MAPK activity.
Figure5. CaR-evoked proliferation is dependent on MAPK signalling:
Activation of the CaR using the Calcimimetic R568 (1μM) at low extracellular Ca 2+ (0.5mM) significantly increased the % of cells undergoing proliferation (P<0.01, n=3). This CaR mediated increase in cell turnover was inhibited by both PD098059 (71%) and SU1498 (93%) (100μM; P<0.001, n=3).
The effect of cell architecture on CaR-mediated proliferation:
The concentrations of free calcium ions in the systemic circulation are rigidly maintained at 1.1-1.3mM. However, it has been suggested that local fluctuations within small inter-cellular spaces of pancreatic islets may change within the mM range [41] . These local changes are sufficient to activate the CaR and thus influence β-cell proliferation. When a neutralising antibody to the extracellular domain of ECAD was used to further reduce ECAD-ligation and cell-coupling between cells in a 2-dimensional monolayer ( Fig 2B, top panel; 48hr treatment with 60μg/mL anti-uvomorulin, Sigma, UK), the cells appeared phase bright and demonstrated a further 50% reduction in CaR-expression (Fig 2B, 50±5 .5%, n=3; P<0.05) when compared to monolayer control cells treated with mouse IgG.
Figure 6: Loss of cell-to-cell contact reduces CaR-mediated proliferation:
Overnight incubation with (68g/ml) immuno-neutralizing anti-E-cadherin decreases cell-cell contact and reduces proliferation. In cells lacking Ecadherin ligation, R568 (1μM) improved cell proliferation compared to E-cadherin-negated MIN6 cells, but was unable to regain the full response to the calcimimetic observed in cells retaining E-cadherin ligation. Data are representative of mean ± SEM where **P<0.01, n=3.
These data suggest an association between close cell-to-cell coupling and CaR-expression in our model. Within a highly coupled 3-dimensional PI, CaR-expression is reduced, whilst neutralising ECADligation lessens cell-to-cell contact and reduces CaR-expression. The degree of BrdU-incorporation in cells treated with anti-ECAD to reduce cell coupling and consequently CaR-expression is similarly reduced 70±10%, P<0.05), suggesting a clear relationship between cell architecture and CaR-evoked proliferation. Addition of the calcimimetic to these non-ligated cells improved proliferation comparable to control levels (109±13%), but was unable to fully regain the R568-evoked effect when applied to cells that retain E-cadherin ligation (190±15%).
IV.
Discussion:
The extracellular calcium sensing receptor (CaR) plays a central role in maintaining systemic Ca 2+ -homeostasis by regulating the secretion of parathyroid hormone and urinary calcium concentration [21] , however, since the identification and characterisation of the CaR [22] , it has become increasingly apparent that this cationic ion binding receptor is found on many tissues not associated with the control of plasma [Ca 2+ ] including; oesophageal [23] and colonic epithelia [24] , the cardiovascular system (reviewed in [25] ), hypothalamic neurons [26] , pancreatic ducts [27] and pancreatic -and -cells [20, [28] [29] . The functional significance of the CaR in tissue not involved in the control of systemic Ca 2+ is not fully understood [30, 31] . In exocrine pancreas it has been suggested that the CaR monitors extracellular Ca 2+ in pancreatic juice to limit the risk of Ca 2+ carbonate stone formation [32] , whilst the receptor may detect changes in levels of dietary Ca 2+ in gastrin secreting cells of the human antrum [33] [34] [35] . However, a more global explanation for the role of the CaR in these disparate tissues could be in its ability to detect local, often acute, fluctuations in Ca , mediating cellto-cell communication by coupling the stimulus to an intracellular response/function.
The possibility that local changes in extracellular Ca 2+ resulting from the efflux of mobilised Ca 2+ in one cell are sufficient to activate the CaR on an adjacent cell was elegantly demonstrated in a model system of the kidney epithelium [36] . In this novel study, Ca 2+ -extrusion from fibroblasts was to activate the CaR on cocultured HEK cells to elicit a response [37] . In the pancreas we have long argued that cell-to-cell communication improves the functional responsiveness of cells and augments insulin secretion [38] . Activation of the CaR using receptor-specific calcimimetics [39] enhances insulin secretion from human islets [29] . Secretory granules contain high concentrations of Ca 2+ which is released upon exocytosis [40] . An early investigation to determine the inter-cellular calcium concentration within pancreatic islets used Ca 2+ -sensitive microelectrodes to detect millimolar changes in [Ca 2+ ] e following glucose-stimulation [41] . This evidence supports the concept of local 'hot-spots' of extracellular Ca 2+ which are able to reach sufficient concentrations to activate the CaR on neighbouring cells.
We have previously shown that activation of the CaR was associated with rapid and transient increases in cytosolic calcium, and that these changes were accompanied by the initiation of a marked but transient insulin secretory response [42, 43] . Our earlier studies confirmed that the CaR has an important role mediating cell-tocell communication within islets to co-ordinate insulin secretory responses. In the present study we have confirmed that activation of the CaR, via either elevated extracellular calcium or co-administration of the calcimimetic R568, also increases β-cell turnover. Moreover, the proliferative effects of CaR appear dependent on whether the cells are grown as monolayers or pseudoislets. There is a 75% increase in CaR expression in cells configured as monolayers compared to passage-matched cells grown as pseudoislets and further downregulation of the CaR was observed in cells exhibiting reduced cell-cell contact when treated to neutralise Ecadherin ligation. Under these conditions, CaR-stimulated proliferation was reduced by 70±10% compared to IgG-treated controls. These data suggest close cell-to-cell contact influences CaR signalling and implicates other molecules such as the adherens junction proteins.
In human embryonic kidney (HEK293) cells increasing [Ca 2+ ] o in cells overexpressing the CaR stimulates p38 and p42/44 (ERK2 and ERK1) MAP kinases [14] . Activation of the receptor also enhances cell proliferation in skeletal metastatic prostate cell lines [15] . In the current study, CaR-mediated increases in β-cell proliferation were markedly reduced by inhibition of both MEK and ERK. These finding suggest that β-cell proliferation involves p42/44 MAPK [45, 46] . Our observations agree with Gray and colleagues (2006) [29] , who found that insulin secretion, induced by CaR stimulation, was linked to the activation of p42/44. However, even high concentrations of the inhibitors did not completely block all proliferation, suggesting that the remaining cell turnover must occur via p42/44 MAPK independent pathway. The p38-MAPK pathway has been associated with cellular responses to stress [47] and the proliferative response of T lymphocytes [48] . An early study by the King's Group demonstrated the regulatory role of p38 MAPK in MIN6 cell proliferation, as inhibited by SB203580 [13] .
Defining factors/mechanisms that regulate proliferation of -cells is of considerable importance in understanding maintenance of -cell mass in vivo. Furthermore, this information may ultimately be used to isolate and expand -cells for therapeutic use. This study investigates how different cell configurations mediate CaR expression and ultimately regulate -cell proliferation in cultures of varying cell-to-cell contact.
